Literature DB >> 20831277

Improved therapeutic effect of DOX-PLGA-PEG micelles decorated with bivalent fragment HAb18 F(ab')(2) for hepatocellular carcinoma.

Cheng Jin1, Niansong Qian, Wei Zhao, Wenqing Yang, Ling Bai, Hong Wu, Minchang Wang, Wenjie Song, Kefeng Dou.   

Abstract

Although surgery offers the only hope of cure for hepatocellular carcinoma (HCC), patients with inoperable or metastatic disease have a dismal prognosis. Therefore, there is an urgent need for new and effective treatment strategies. Polymeric micelles composed of drug conjugated to a diblock copolymer have attracted great interest for clinical administration of anticancer drugs. In this work, characteristics and cytotoxicity of doxorubicin-poly(d,l-lactic-co-glycolic acid)-poly(ethylene glycol) (DOX-PLGA-PEG) micelle and its targeted micelle decorated with bivalent fragment HAb18 F(ab')(2) for HCC were studied. These micelles possessed spherical morphology and higher loading efficiency. Cellular uptake and accumulation in tumor tissue of micelles was observed. The accumulation of the targeted micelles depends on dual effects of passive and active targeting. The drug-loading micelles showed cytotoxicity on tumor cells in vitro and in vivo. The targeted micelles resulted in significant improvement in therapeutic response. These results suggest that the novel micelles could be a promising candidate with excellent therapeutic efficacy for targeting the drugs to cancer cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20831277     DOI: 10.1021/bm1005992

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  9 in total

Review 1.  Immunoconjugates and long circulating systems: origins, current state of the art and future directions.

Authors:  Alexander Koshkaryev; Rupa Sawant; Madhura Deshpande; Vladimir Torchilin
Journal:  Adv Drug Deliv Rev       Date:  2012-09-03       Impact factor: 15.470

Review 2.  Nanomedicine of synergistic drug combinations for cancer therapy - Strategies and perspectives.

Authors:  Rui Xue Zhang; Ho Lun Wong; Hui Yi Xue; June Young Eoh; Xiao Yu Wu
Journal:  J Control Release       Date:  2016-06-08       Impact factor: 9.776

3.  Polymeric nanoparticles conjugate a novel heptapeptide as an epidermal growth factor receptor-active targeting ligand for doxorubicin.

Authors:  Chia Wen Liu; Wen Jen Lin
Journal:  Int J Nanomedicine       Date:  2012-08-29

4.  Enhanced antitumor effect of anti-tissue factor antibody-conjugated epirubicin-incorporating micelles in xenograft models.

Authors:  Yoshiyuki Yamamoto; Ichinosuke Hyodo; Yoshikatsu Koga; Ryo Tsumura; Ryuta Sato; Toshihumi Obonai; Hirobumi Fuchigami; Fumiaki Furuya; Masahiro Yasunaga; Mitsunori Harada; Yasuki Kato; Atsushi Ohtsu; Yasuhiro Matsumura
Journal:  Cancer Sci       Date:  2015-03-23       Impact factor: 6.716

5.  Preparation of poly(β-L-malic acid)-based charge-conversional nanoconjugates for tumor-specific uptake and cellular delivery.

Authors:  Qing Zhou; Tiehong Yang; Youbei Qiao; Songyan Guo; Lin Zhu; Hong Wu
Journal:  Int J Nanomedicine       Date:  2015-03-10

Review 6.  Ligand-based targeted therapy: a novel strategy for hepatocellular carcinoma.

Authors:  Min Li; Weiyue Zhang; Birong Wang; Yang Gao; Zifang Song; Qi Chang Zheng
Journal:  Int J Nanomedicine       Date:  2016-10-31

7.  Self-assembled biodegradable polymeric micelles to improve dapoxetine delivery across the blood-brain barrier.

Authors:  Mohammed As Abourehab; Osama Aa Ahmed; Gehan F Balata; Waleed H Almalki
Journal:  Int J Nanomedicine       Date:  2018-06-26

Review 8.  Cancer nanotechnology: Enhancing tumor cell response to chemotherapy for hepatocellular carcinoma therapy.

Authors:  Yongbing Sun; Wen Ma; Yuanyuan Yang; Mengxue He; Aimin Li; Lei Bai; Bin Yu; Zhiqiang Yu
Journal:  Asian J Pharm Sci       Date:  2019-06-12       Impact factor: 6.598

Review 9.  Targeting tumor microenvironment with PEG-based amphiphilic nanoparticles to overcome chemoresistance.

Authors:  Shizhu Chen; Keni Yang; Ruslan G Tuguntaev; Anbu Mozhi; Jinchao Zhang; Paul C Wang; Xing-Jie Liang
Journal:  Nanomedicine       Date:  2015-12-17       Impact factor: 5.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.